General Information


DRACP ID  DRACP04077

Peptide Name  

Sequence  CASYFCRWWWRR

Sequence Length  12

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C81H106N24O15S2

Absent amino acids  DEGHIKLMNPQTV

Common amino acids  RW

Mass  191638

Pl  9.59

Basic residues  3

Acidic residues  0

Hydrophobic residues  5

Net charge  3

Boman Index  -3396

Hydrophobicity  -72.5

Aliphatic Index  8.33

Half Life 
  Mammalian:
  Yeast:
  E.coli:

Extinction Coefficient cystines  18115

Absorbance 280nm  1646.82

Polar residues  4

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 33042031

Title  Hybrid Antimicrobial Peptide Targeting Staphylococcus aureu s and Displaying Anti-infective Activity in a Murine Model

Doi Not available

Year  2020

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  16899

DRACP is developed by Dr.Zheng's team.